Internet Archive Scholar

Study on the Anti-tumor Mechanism of Immunological Checkpoint Inhibitor PD-1

ZHANG Yu, ZHANG Tong, WANG Shinong, XUE Hui, ZUO Wenbo, LI Yannan, JIN Chenghao
2020 unpublished

Preserved Fulltext

Web Archive Capture PDF (143.6 kB)
https://web.archive.org/web/20200818143810/https://tind-customer-agecon.s3.amazonaws.com/c26ec904-a65e-45a6-a808-0b945f18df8b?response-content-disposition=attachment%3B%20filename%2A%3DUTF-8%27%27Study%2520on%2520the%2520Anti-tumor%2520Mechanism%2520of%2520Immunological%2520Checkpoint%2520Inhibitor%2520PD-1.pdf&response-content-type=application%2Fpdf&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Expires=86400&X-Amz-Credential=AKIAXL7W7Q3XHXDVDQYS%2F20200818%2Feu-west-1%2Fs3%2Faws4_request&X-Amz-SignedHeaders=host&X-Amz-Date=20200818T143809Z&X-Amz-Signature=6475370c634d4597eee1451a0dd15758795bc6b61ec12d47d0d18d0a4ab16e41

A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL. The file type is application/pdf.

In recent years, the research of programmed death factor-1 (PD-1) and its ligand (PD-L1) has made a great breakthrough in tumor therapy, and it is expected to change the clinical treatment manner of anti-tumor. In this paper, the role and mechanism of PD-1 inhibitors in anti-tumor are reviewed, thereby promoting their clinical application in anti-tumor immunotherapy.
doi:10.22004/ag.econ.304122 fatcat:ocakejvpavesnpzst4v3m5evr4
Citation

ZHANG Yu, ZHANG Tong, WANG Shinong, XUE Hui, ZUO Wenbo, LI Yannan, JIN Chenghao. "Study on the Anti-tumor Mechanism of Immunological Checkpoint Inhibitor PD-1." (2020)